Recently at the CBI Pharmaceutical Compliance Congress a group of State, DOJ and US Attorneys thoroughly reviewed the life cycle of a Qui Tam case and the questions companies should be asking themselves about their compliance programs. The enforcement panel at CBI included four U.S. Attorneys and two government health care fraud officials: Zane Memeger (E.D.Pa.) William C. Killian (E.D. Tn.) Sanford Coates (W.D. Ok.) Bill Nettles (D. S.C.) Ben Singer, Deputy Chief, DOJ Criminal Division, Fraud Section; and Rebecca Martin, Deputy Chief, Civil Frauds Unit (S.D.N.Y.) Bringing Parallel Criminal and Civil Actions In the opening discussion, Nettles explained how his office evaluates the civil and criminal aspects of healthcare fraud. He first emphasized that his office has "shifted focus a lot" on white collar and healthcare fraud cases, noting that he was putting a lot of resources into this area. Nettles explained that his "white collar team" will make a decision early on "based on evidence" whether to pursue civil or criminal charges in parallel. - See more at: http://www.policymed.com/#sthash.EBkBxXUh.dpuf
No comments:
Post a Comment